[Federal Register Volume 80, Number 67 (Wednesday, April 8, 2015)]
[Notices]
[Pages 18852-18853]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-07981]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, Office of Science Policy, Office of 
Biotechnology Activities; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the meeting of the 
National Science Advisory Board for Biosecurity (NSABB).

    Name of Committee: National Science Advisory Board for 
Biosecurity.
    Date: May 5, 2015.
    Time: 8:30 a.m.--3:30 p.m. Eastern.
    Agenda: Presentations and discussions regarding: (1) NSABB's 
proposed framework for guiding risk and benefit assessments of gain-
of-function (GOF) studies involving pathogens with pandemic 
potential; (2) overview of conducting the risk and benefit 
assessments; (3) planning for future NSABB deliberations on the GOF 
issue; and (4) other business of the Board.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31, 6th Floor Conference 10, Bethesda, Maryland 20892.
    Contact Person: Carolyn Mosby, NSABB Program Assistant, NIH 
Office of Biotechnology Activities, 6705 Rockledge Drive, Suite 750, 
Bethesda, Maryland 20892, (301) 435-5504, <a href="/cdn-cgi/l/email-protection#d7b4b6a5b8bbaeb9f9bab8a4b5ae97b9bebff9b0b8a1"><span class="__cf_email__" data-cfemail="1d7e7c6f727164733370726e7f645d737475337a726b">[email protected]</span></a>.
    Under authority 42 U.S.C. 217a, Section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established the National Science Advisory Board for Biosecurity 
(NSABB) to provide advice regarding federal oversight of dual use 
research, defined as

[[Page 18853]]

legitimate biological research that generates information and 
technologies that could be misused to pose a biological threat to 
public health and/or national security.
    The meeting will be open to the public and will also be webcast 
as space will be limited. Persons planning to attend or view via the 
webcast may pre-register online using the link provided below or by 
calling Palladian Partners, Inc. (Contact: Monica Barnette at 301-
650-8660). Online and telephone registration will close at 12:00 
p.m. Eastern on May 4, 2015. After that time, attendees may register 
onsite on the day of the meeting. Individuals who plan to attend and 
need special assistance, such as sign language interpretation or 
other reasonable accommodations, should indicate these requirements 
upon registration.
    Please Note: The meeting agenda, proposed draft framework, and 
links to the online registration and webcast will be available at: 
http://osp.od.nih.gov/office-biotechnology-activities/biosecurity/nsabb/nsabb-meetings-and-conferences. Please check this Web site for 
updates.
    Public Comments: Time will be allotted on the agenda for oral 
public comment, with individual presentations time-limited to 
facilitate broad input from multiple speakers. Any member of the 
public interested in presenting comments relevant to the mission of 
the NSABB should indicate so upon registration. Sign-ups for oral 
comments will be restricted to one per person or organization 
representative per comment period. In the event that time does not 
allow for all attendees interested in presenting oral comments to do 
so at the meeting, any interested person may file written comments 
with the Board via an email sent to <a href="/cdn-cgi/l/email-protection#701e03111212301f145e1e19185e171f06"><span class="__cf_email__" data-cfemail="d1bfa2b0b3b391beb5ffbfb8b9ffb6bea7">[email protected]</span></a> or by regular 
mail sent to the Contact Person listed on this notice. In addition, 
any interested person may submit written comments to the NSABB at 
any time via either of these methods. Comments received by 5:00 p.m. 
Eastern on April 28, 2015 will be relayed to the Board prior to the 
NSABB meeting. Written statements should include the name, address, 
telephone number and when applicable, the professional affiliation 
of the interested person. Any written comments received after the 
deadline will be provided to the Board either before or after the 
meeting, depending on the volume of comments received and the time 
required to process them in accordance with privacy regulations and 
other applicable Federal policies.
    Please Note: In the interest of security, NIH has instituted 
stringent procedures for entrance onto the NIH campus. All visitor 
vehicles, including taxis, hotel, and airport shuttles will be 
inspected before being allowed on campus. Visitors will be asked to 
show one form of identification (for example, a government-issued 
photo ID, driver's license, or passport) and to state the purpose of 
their visit.

    Dated: April 2, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-07981 Filed 4-7-15; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>